Development of cell-specific and organelle-specific delivery systems by surface modification of lipid-based pharmaceutical nanocarriers

The use of lipid-based pharmaceutical nanocarriers, such as lipid-core polymeric micelles and liposomes have improved the pharmacokinetic and pharmacodynamic properties of many pharmaceuticals, especially in chemotherapy. These delivery systems have not only helped in increasing the solubility of po...

Full description

Bibliographic Details
Published:
Online Access:http://hdl.handle.net/2047/d20002485
id ndltd-NEU--neu-1732
record_format oai_dc
spelling ndltd-NEU--neu-17322021-05-25T05:10:10ZDevelopment of cell-specific and organelle-specific delivery systems by surface modification of lipid-based pharmaceutical nanocarriersThe use of lipid-based pharmaceutical nanocarriers, such as lipid-core polymeric micelles and liposomes have improved the pharmacokinetic and pharmacodynamic properties of many pharmaceuticals, especially in chemotherapy. These delivery systems have not only helped in increasing the solubility of poorly soluble chemotherapeutic drugs but have also acted as reservoir of large molecular weight active pharmaceutical ingredients (API) like proteins. The objective of the thesis was to explore surface modification options to further enhance the delivery of pro-apoptotic small molecules for cell-specific delivery and proteins for intracellular delivery. The thesis has been divided into two sections.http://hdl.handle.net/2047/d20002485
collection NDLTD
sources NDLTD
description The use of lipid-based pharmaceutical nanocarriers, such as lipid-core polymeric micelles and liposomes have improved the pharmacokinetic and pharmacodynamic properties of many pharmaceuticals, especially in chemotherapy. These delivery systems have not only helped in increasing the solubility of poorly soluble chemotherapeutic drugs but have also acted as reservoir of large molecular weight active pharmaceutical ingredients (API) like proteins. The objective of the thesis was to explore surface modification options to further enhance the delivery of pro-apoptotic small molecules for cell-specific delivery and proteins for intracellular delivery. The thesis has been divided into two sections.
title Development of cell-specific and organelle-specific delivery systems by surface modification of lipid-based pharmaceutical nanocarriers
spellingShingle Development of cell-specific and organelle-specific delivery systems by surface modification of lipid-based pharmaceutical nanocarriers
title_short Development of cell-specific and organelle-specific delivery systems by surface modification of lipid-based pharmaceutical nanocarriers
title_full Development of cell-specific and organelle-specific delivery systems by surface modification of lipid-based pharmaceutical nanocarriers
title_fullStr Development of cell-specific and organelle-specific delivery systems by surface modification of lipid-based pharmaceutical nanocarriers
title_full_unstemmed Development of cell-specific and organelle-specific delivery systems by surface modification of lipid-based pharmaceutical nanocarriers
title_sort development of cell-specific and organelle-specific delivery systems by surface modification of lipid-based pharmaceutical nanocarriers
publishDate
url http://hdl.handle.net/2047/d20002485
_version_ 1719406060629917696